{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T16:10:11Z","timestamp":1745165411267,"version":"3.40.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,20]]},"DOI":"10.7759\/cureus.82629","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T15:39:16Z","timestamp":1745163556000},"source":"Crossref","is-referenced-by-count":0,"title":["Budd-Chiari Syndrome Secondary to Myelofibrosis in a Patient With Polycythemia Vera: A 16-Year Disease Progression Case Highlighting JAK2 Mutation Pathogenesis"],"prefix":"10.7759","author":[{"given":"Huyu","family":"Jiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)62109-0","article-title":"Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome","volume":"65","author":"Ludwig J","year":"1990","unstructured":"Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc. 1990, 65:51-5. 10.1016\/s0025-6196(12)62109-0","journal-title":"Mayo Clin Proc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","unstructured":"EASL Clinical Practice Guidelines. management of hepatocellular carcinoma. J Hepatol. 2018, 69:182-236. 10.1016\/j.jhep.2018.03.019","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2018.10.014","article-title":"Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"43","author":"Li Y","year":"2019","unstructured":"Li Y, De Stefano V, Li H, Zheng K, Bai Z, Guo X, Qi X. Epidemiology of Budd-Chiari syndrome: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2019, 43:468-74. 10.1016\/j.clinre.2018.10.014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-09-376517","article-title":"Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis","volume":"120","author":"Smalberg JH","year":"2012","unstructured":"Smalberg JH, Arends LR, Valla DC, Kiladjian JJ, Janssen HL, Leebeek FW. Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis. Blood. 2012, 120:4921-8. 10.1182\/blood-2011-09-376517","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26306","article-title":"Good long-term outcome of Budd-Chiari syndrome with a step-wise management","volume":"57","author":"Seijo S","year":"2013","unstructured":"Seijo S, Plessier A, Hoekstra J, et al.. Good long-term outcome of Budd-Chiari syndrome with a step-wise management. Hepatology. 2013, 57:1962-8. 10.1002\/hep.26306","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(96)00028-8","article-title":"Mixed myelodysplastic and myeloproliferative syndromes","volume":"20","author":"Neuwirtov\u00e1 R","year":"1996","unstructured":"Neuwirtov\u00e1 R, Mocikov\u00e1 K, Musilov\u00e1 J, Jel\u00ednek J, Havl\u00ed\u010dek F, Michalov\u00e1 K, Adamkov M. Mixed myelodysplastic and myeloproliferative syndromes. Leuk Res. 1996, 20:717-26. 10.1016\/0145-2126(96)00028-8","journal-title":"Leuk Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"Tefferi A","year":"2000","unstructured":"Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000, 342:1255-65. 10.1056\/NEJM200004273421706","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber DA","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, et al.. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022, 140:1200-28. 10.1182\/blood.2022015850","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors","volume":"5","author":"Cerquozzi S","year":"2015","unstructured":"Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015, 5:e366. 10.1038\/bcj.2015.95","journal-title":"Blood Cancer J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic\u00a0Neoplasms","volume":"36","author":"Khoury JD","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic\u00a0Neoplasms. Leukemia. 2022, 36:1703-19. 10.1038\/s41375-022-01613-1","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi A","year":"2023","unstructured":"Tefferi A. Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023, 98:801-21. 10.1002\/ajh.26857","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01471-z","article-title":"Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety","volume":"16","author":"Verstovsek S","year":"2023","unstructured":"Verstovsek S, Mesa RA, Livingston RA, Hu W, Mascarenhas J. Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety. J Hematol Oncol. 2023, 16:82. 10.1186\/s13045-023-01471-z","journal-title":"J Hematol Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-025-01235-7","article-title":"Evolution of WHO diagnostic criteria in \"Classical Myeloproliferative Neoplasms\" compared with the International Consensus Classification","volume":"15","author":"Thiele J","year":"2025","unstructured":"Thiele J, Kvasnicka HM, Gianelli U, et al.. Evolution of WHO diagnostic criteria in \"Classical Myeloproliferative Neoplasms\" compared with the International Consensus Classification. Blood Cancer J. 2025, 15:31. 10.1038\/s41408-025-01235-7","journal-title":"Blood Cancer J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020282","article-title":"The Budd-Chiari syndrome","volume":"350","author":"Menon KV","year":"2004","unstructured":"Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004, 350:578-85. 10.1056\/NEJMra020282","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2207738","article-title":"Primary Budd-Chiari syndrome","volume":"388","author":"Garcia-Pag\u00e1n JC","year":"2023","unstructured":"Garcia-Pag\u00e1n JC, Valla DC. Primary Budd-Chiari syndrome. N Engl J Med. 2023, 388:1307-16. 10.1056\/NEJMra2207738","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10189-4","article-title":"Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL)","volume":"15","author":"Shukla A","year":"2021","unstructured":"Shukla A, Shreshtha A, Mukund A, et al.. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int. 2021, 15:531-67. 10.1007\/s12072-021-10189-4","journal-title":"Hepatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208500","article-title":"Cardiovascular events and intensity of treatment in polycythemia vera","volume":"368","author":"Marchioli R","year":"2013","unstructured":"Marchioli R, Finazzi G, Specchia G, et al.. Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med. 2013, 368:22-33. 10.1056\/NEJMoa1208500","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-20399-x","article-title":"Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis","volume":"12","author":"Mukhiya G","year":"2022","unstructured":"Mukhiya G, Zhou X, Han X, Jiao D, Pokhrel G, Li Y, Pokhrel S. Evaluation of outcome from endovascular therapy for Budd-Chiari syndrome: a systematic review and meta-analysis. Sci Rep. 2022, 12:16166. 10.1038\/s41598-022-20399-x","journal-title":"Sci Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.05.009","article-title":"Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension","volume":"43","author":"de Franchis R","year":"2005","unstructured":"de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol. 2005, 43:167-76. 10.1016\/j.jhep.2005.05.009","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(02)00434-8","article-title":"Budd-Chiari syndrome: a review by an expert panel","volume":"38","author":"Janssen HLA","year":"2003","unstructured":"Janssen HLA, Garcia-Pagan JC, Elias E, et al.. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003, 38:364-71. 10.1016\/s0168-8278(02)00434-8","journal-title":"J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/360806-budd-chiari-syndrome-secondary-to-myelofibrosis-in-a-patient-with-polycythemia-vera-a-16-year-disease-progression-case-highlighting-jak2-mutation-pathogenesis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T15:39:16Z","timestamp":1745163556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/360806-budd-chiari-syndrome-secondary-to-myelofibrosis-in-a-patient-with-polycythemia-vera-a-16-year-disease-progression-case-highlighting-jak2-mutation-pathogenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.82629","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,20]]}}}